Cardiovascular disease (CVD) due to atherosclerosis of the arterial vessel wall and to thrombosis is the foremost cause of premature mortality in Europe, US, and is also increasingly common in developing countries. Prevention and treatment of dyslipidemias should always be considered within the broader framework of CVD prevention.
Guidelines summarize and evaluate all available evidence with the aim of assisting physicians in selecting the best management strategies for an individual patient, with a given condition, taking into account the impact on outcome, as well as the risk–benefit ratio of particular diagnostic or therapeutic means. Guidelines and recommendations should help physicians to make decisions in their daily practice.
Different guidelines for dyslipidemias exist in Europe and US, regularly updated, but not always known and implemented or used by physicians and patients.
To help guidelines developers to have a better understanding of the unmet needs and knowledge gaps, TMA propose you to answer the following questionnaire. It will take you less than 5 min to fill in, and for every filled questionnaire, TMA promises to pay one euro, on your behalf, to a local patients’ association.
This questionnaire is anonymous and you will have the opportunity to consult the results of this survey on-line very soon.
TMA thanks you for your help!